Why the study?
Does continuous blood gas monitoring improve adherence to blood gas management protocols in patients undergoing cardiopulmonary bypass?
RCT (n=100)
Single-blind
Randomized into two groups
Does continuous blood gas monitoring improve adherence to blood gas management protocols in patients undergoing cardiopulmonary bypass?
Answers are grounded in this paper and cite their sources.
Continuous in-line blood gas monitoring during cardiopulmonary bypass significantly improves adherence to pCO2 management protocols compared to intermittent monitoring.
The CDI-500 (Terumo Cardiovascular Systems Corp., Ann Arbor, MI) in-line blood gas monitoring device has been in clinical practice for more than a decade. Few randomized studies have evaluated the value of this device with respect to improved perfusion management. We routinely use automated continuous quality indicator programs at our institutions to assess perfusion management.
No takes yet. Share an insight, caveat, or question.
Ottens et al. (2007) conducted an RCT in Patients undergoing cardiopulmonary bypass (n=100). Continuous blood gas monitoring (CDI-500) with visible data and alarms vs. Standard intermittent blood gas monitoring (continuous monitoring blinded) was evaluated on Quality indicator compliance (pCO2 within 35-45 mmHg) (p=0.013).
Synapse has enriched 10 related papers. Consider them for comparative context: